Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
International Journal of Molecular Sciences|October 16, 2024
A Synbiotic Combining Chitin-Glucan and <i>Lactobacillus acidophilus</i> NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBSLena Capirchio, Christel Rousseaux, Caroline Dubuquoy, et al.
Food Research International (Ottawa, Ont.)|March 22, 2024
Food additives impair gut microbiota from healthy individuals and IBD patients in a colonic in vitro fermentation modelIrma Gonza, Elizabeth Goya-Jorge, Caroline Douny, et al.
Rheumatology (Oxford, England)|September 6, 2011
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useJohanna M W Hazes, Pierre G Coulie, Vincent Geenen, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Rheumatology (Oxford, England)|July 2, 2010
Vaccinations in patients with immune-mediated inflammatory diseasesJean-François Rahier, Michel Moutschen, Alfons Van Gompel, et al.
Journal of Crohn'S & Colitis|April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trialEdouard Louis, Robert Löfberg, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|September 2, 2021
Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical StudySophie Vieujean, Jean-Philippe Loly, Layla Boutaffala, et al.
Frontiers in Molecular Biosciences|August 2, 2021
A Blood Exosomal miRNA Signature in Acute Respiratory Distress SyndromeGilles Parzibut, Monique Henket, Catherine Moermans, et al.
BMJ Open Gastroenterology|May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort studySilvio Danese, Ailsa Hart, Axel Dignass, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2020
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple CentersLieven Pouillon, Thomas Remen, Caroline Amicone, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
International Journal of Molecular Sciences|October 16, 2024
A Synbiotic Combining Chitin-Glucan and <i>Lactobacillus acidophilus</i> NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBSLena Capirchio, Christel Rousseaux, Caroline Dubuquoy, et al.
Food Research International (Ottawa, Ont.)|March 22, 2024
Food additives impair gut microbiota from healthy individuals and IBD patients in a colonic in vitro fermentation modelIrma Gonza, Elizabeth Goya-Jorge, Caroline Douny, et al.
Rheumatology (Oxford, England)|September 6, 2011
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useJohanna M W Hazes, Pierre G Coulie, Vincent Geenen, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Rheumatology (Oxford, England)|July 2, 2010
Vaccinations in patients with immune-mediated inflammatory diseasesJean-François Rahier, Michel Moutschen, Alfons Van Gompel, et al.
Journal of Crohn'S & Colitis|April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trialEdouard Louis, Robert Löfberg, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|September 2, 2021
Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical StudySophie Vieujean, Jean-Philippe Loly, Layla Boutaffala, et al.
Frontiers in Molecular Biosciences|August 2, 2021
A Blood Exosomal miRNA Signature in Acute Respiratory Distress SyndromeGilles Parzibut, Monique Henket, Catherine Moermans, et al.
BMJ Open Gastroenterology|May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort studySilvio Danese, Ailsa Hart, Axel Dignass, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2020
Risk of Late Postoperative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple CentersLieven Pouillon, Thomas Remen, Caroline Amicone, et al.
Pageof 29